# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA658547 | F | In vitro growth inhibition against CNS cancer SF-268 cell line was reported. | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
2. | ALA658548 | F | In vitro total growth inhibition against CNS cancer SF-268 cell lines was reported. | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
3. | ALA658148 | F | Compound was tested in vitro for its antitumor activity against CNS cancer cell line SF-268 (50% growth inhibition of tumor cells after 48 hr exposure ) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
4. | ALA681015 | F | Cytotoxic activity against cellular metabolic activity of Glioma SF-268 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
5. | ALA697445 | F | Tested for induction of cellular death in Human ZNS SF-268 tumor cell line in Propidium Iodide Monolayer Assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
6. | ALA697446 | F | Tested for induction of cellular death in Human ZNS SF-268 tumor cell line in Propidium Iodide Monolayer Assay; Not determined | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA805822 | F | In vitro anti-cancer activity against SF 268(CNS) human tumor cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA805823 | F | In vitro anti-cancer activity against SF 268(CNS) human tumor cell lines | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
9. | ALA805824 | F | In vitro anti-cancer activity against SF 268(CNS) human tumor cell lines; ND is no data | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
10. | ALA805982 | F | In vitro growth inhibition of central nervous system SF-268 cell line. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
11. | ALA805983 | F | Growth inhibitory activity was determined against SF-268 cancer cell line of CNS cancer | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
12. | ALA805984 | F | Inhibition of growth of SF-268 CNS cancer cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
13. | ALA805985 | F | Inhibition of in vitro tumor cell growth of SF-268 cancer cell line; Not tested | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA805986 | F | Inhibition of in vitro tumor cell growth of SF-268, CNS tumor cell line | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
15. | ALA805987 | F | Cytotoxicity against NCI tumor panel, SF-268 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA805988 | F | Concentration of compound that cause 50% cytotoxicity of SF-268 CNS cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA805989 | F | In vitro anticancer activity against SF-268 (CNS) cell line | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
18. | ALA803689 | F | Inhibition of CNS SF-268 cell proliferation | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
19. | ALA803690 | F | Cell growth inhibition of central nervous system (CNS) SF-268 cells, expressed as 50% reduction in the net protein increase | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
20. | ALA803691 | F | Compound was tested for cancer cell line growth inhibition against human central nervous system (SF268) cell line | Homo sapiens | 2 | cell-based format | Scientific Literature |